Navigation Links
Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Date:10/17/2007

BASINGSTOKE, England, Oct. 17 /PRNewswire-FirstCall/ -- Below is updated text of Shire plc's conference call notification. Please note U.S. release times and conference call times have been updated from an earlier release.

Shire PLC (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company, will announce third quarter 2007 earnings on Thursday 1 November 2007.

Results press release will be issued at: 12:00 GMT / 08:00 ET

Investor meeting and conference call time: 14:30 GMT / 10:30 ET

Live conference call for investors:

Matthew Emmens, Chief Executive Officer and Angus Russell, Chief Financial Officer will host the live conference call for investors at 14:30 GMT/10:30 ET.

Please RSVP ssalah@shire.com (T: +44(0)1256-894-160) for this conference call.

The details of the conference call are as follows:

UK dial in: +44(0)800-953-0810,

US dial in: +1-866-789-2220,

International dial in: +44(0)1452-560-068,

Password/Conf ID: 20443623#

Live Webcast:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:

UK dial in: +44(0)800-953-1533,

US dial in: +1-866-247-4222,

International dial in: +44(0)1452-55-00-00,

Pin code: 20443623#

Webcast replay:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

* Email verification is required

Notes to editors

Shire PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focu
'/>"/>

SOURCE Shire PLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Visions: Broderick says Wisconsin should be in top third in venture capital
2. Third Wave files countersuit vs. Digene in patent case
3. Third Wave reports net loss of $18.9M for 2006
4. Stratagene to pay Third Wave $10.75M in patent case
5. Third Wave responds to Digene patent lawsuit
6. Third Wave seeks approval of Cystic Fibrosis test
7. Third Wave Technologies to raise $14.9M through private debt
8. Venture capital above $6B for third straight quarter
9. Third Wave reports $5.2M third quarter loss
10. Third Wave reports another loss, stronger sales
11. Napier joins board of Third Wave Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... STOCKHOLM, November 20 Karolins...n Investment Fund (EIF) has entered into a,co-inve...nt fund will be,managed by Karolinska Development ...arly-stage pharmaceutical and medical technology c... the co-investment fund. The agreement,represents ...
(Date:11/19/2009)...AGEN, Nov. 19 Danish Prince Joachi...ic ethanol plant in Kalundborg, Denmark, on Wednes...,s first and largest 2nd generation ethanol demons...mes are used in the plant,s innovative process for... Danisco, was the first to market with commercial ...
(Date:11/19/2009)...SDA, Md., Nov. 19 Spheri...iotechnology for diabetes therapy, and a provider ... food, supplement, biotechnology and pharmaceutica...y,s Annual Meeting of Shareholders. ,, At the m...aq: SPEX ) elected the following members to the B...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies For...o Coordinate Best Practices in Risk Reduction ,F...wide Gene Synthesis Capacity , ...ld’s leading gene synthesis companies today ...screening protocol to promote biosecurity in the g...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...w.thirdbiotech.com ), a biotechnology incubator an...Kemeta, a medical device company,specializing in t...ensing,technology and products, has become ThirdBi...om.com/cgi-bin/prnh/20070911/LATU119LOGO ), "We,v...nization for,bringing together the life sciences i...
...Call/ -- China Yingxia,International, Inc. (OTC Bu...ny"), a leading provider in the nutraceutical indu...istribution of organic nutritional food,products, ...ple,s Republic,of China ("PRC"), announced today i...t 15, 2008, at 9:00 a.m. EDT, to discuss the Compa...
...SM), a developer of follow-on biologics and biopha...d quarter and six-months ended June 30, 2008., R...Program -- Completed clinical trial demonstrat...ny,s recombinant human granulocyte colony stimulat...approved G-CSF product for the treatment of...
Other Biology Technology:ThirdBiotech Announces Kemeta as Newest Sponsor 2China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results 2Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 2Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 3Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 4Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 5Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 6Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 7Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 8Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 9Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 10
(Date:11/20/2009)...oduction of flax shives, and generated from Brass...those which engulf fields in spring, can be used t...wo studies carried out by Spanish and Dutch resear...Sustainable Energy Reviews . , "These studies eva...oduction of bioethanol from two, as yet unexploite...
(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...
(Date:11/19/2009)...brain chemical with an unwieldy name: 4-hydroxybut...used as a date-rape drug. , Now, a team of Ohio...s by which 4-HB is metabolized by the body. "This ... Gibson, professor and chair of biological science...r of the research team. "It may provide new clues...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Public Call for Participation on National Board of Certification for Medical Interpreters 48574 1Public Call for Participation on National Board of Certification for Medical Interpreters 48574 2Public Call for Participation on National Board of Certification for Medical Interpreters 48574 3Mobile Massage Team to Sponsor and Exhibit at First Annual Working Wellness Expo 48572 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 2Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 3Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 4
...ANOVER, NH A group of Dartmouth researchers has f...ed with chromosome segregation during cell divisio...ut the fundamental workings of cells, and contribu...g, as it does with cancerous cells. , The resear...ted to the motor proteins that power diverse cellu...
...A JOLLA, Calif., January 9, 2009 -- Researchers at...am) have shown that search algorithms used in digi...fective multi-drug combinations. The study, led by...in the December 26, 2008, issue of PLoS Computati...ithm, which was developed for digital communicatio...
...OBOKEN, N.J. Citing the importance of proper comm...ens Institute of Technology has received a grant t... undergraduate students. , Through a $25,000 gra...e Writing and Communications at the Institute (WCI...ops to engineering students in their junior and se...
Other Biology News:Dartmouth researchers find new protein function 2Digital communication technology helps clear path to personalized therapies 2Stevens receives $25,000 grant from the Engineering Information Foundation 2
Silencer Pre-designed siRNA, standard purity, annealed from Ambion
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Custom siRNA, standard purity from Ambion
Custom siRNA, standard purity from Ambion
Biology Products: